<DOC>
	<DOC>NCT00997347</DOC>
	<brief_summary>This open-label, comparative study will compare the efficacy, safety, and acceptability of 200 mg mifepristone followed in 24-48 hours by 800mcg buccal misoprostol or 400mcg sublingual misoprostol for termination of pregnancy in existing outpatient early medical abortion services among women 57-63 days' versus 64-70 days' gestation.</brief_summary>
	<brief_title>The Extended Gestational Age Medical Abortion Study</brief_title>
	<detailed_description />
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>intrauterine pregnancy of greater than 56 days and less than 71 days eligible for medical abortion according to study doctor assessment willing and able to sign consent forms speak English or Spanish (in US sites); speak the local language(s) (in international sites) agree to comply with the study procedures and visit schedule</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>